Not a good buy right now for an impatient trader: price is extended above nearby resistance and short-horizon pattern stats skew negative (next week/month).
Upside is supported by strong merger-driven growth and heavy insider buying, but timing is poor after the breakout; better risk/reward likely on a pullback toward ~$30.7 / ~$29.3.
Trend/Momentum: MACD histogram is positive (0.21) and expanding, confirming bullish momentum.
RSI: 66.2 (upper-neutral, close to overbought) suggests upside is getting crowded and near-term pullback risk is rising.
Moving averages: Converging MAs = trend is improving but not a strong, clean MA uptrend yet.
Levels: Current price $31.21 is above R2 (30.73), implying a breakout/extension; next supports are ~30.73 then pivot ~29.29.
Quant pattern read-through: Similar-pattern projection implies ~70% odds of mild drift lower (-0.76% next day, -1.98% next week, -4.25% next month), consistent with mean-reversion after an extension.
Positive Catalysts
can act as a near-term catalyst if results/guide beat.
Neutral/Negative Catalysts
with RSI near overbought—setup favors consolidation/pullback rather than immediate chase.
Financial Performance
Latest quarter: 2025/Q4.
Growth: Revenue $38.45M (+75.36% YoY) and Net Income $13.87M (+93.70% YoY) show strong reported growth (notably merger-impacted).
EPS data inconsistency: snapshot shows EPS dropped to 0 (-100% YoY) while news cites non-GAAP EPS of $0.92; this suggests accounting/merger impacts and/or GAAP vs non-GAAP differences—headline profitability looks strong, but reported EPS may be noisy.
Overall: fundamentals look improved and scale increased, but near-term trading attractiveness is more about entry timing than business momentum.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: rating downgrade (Hovde Group) from Outperform to Market Perform on 2026-01-07.
Wall Street pro view (pros): improving earnings power/scale post-merger; strong YoY revenue and net income growth; insider buying aligns with confidence.
Wall Street pro view (cons): downgrade suggests upside may be more limited after the run; near-term performance may normalize after merger-driven jump; earnings catalyst could swing sharply either way.
Wall Street analysts forecast COFS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COFS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast COFS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for COFS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 30.330
Low
0
Averages
0
High
0
0
Current: 30.330
Low
0
Averages
0
High
0
Hovde Group
Outperform -> Market Perform
downgrade
AI Analysis
2026-01-07
Reason
Hovde Group
Price Target
AI Analysis
2026-01-07
downgrade
Outperform -> Market Perform
Reason
Hovde Group downgraded ChoiceOne Financial to Market Perform from Outperform.
